| Filed On | Filing |
|---|---|
| 04 Mar 2009 |
Form 3/A: Endo Pharmaceuticals Holdings Inc, 10% owner and 1 other · Endo Pharmaceuticals Solutions Inc.
Holds 55,008,149 shares of Common Stock, par value $.001 per share |
| 16 Aug 2006 |
Form 3/A: LaViscount Joyce N, Chief Accounting Officer
Holds 0 shares of Common stock, par value $0.01 per share |
Loading...